Contacts

MedinCell releases the results of its September 8, 2022 ordinary annual and extraordinary general meeting

September 13, 2022

Adoption of all the proposed resolutions, with the exception of the 31st and 32nd resolutions, as recommended by the Management Board


 MedinCell held its ordinary annual and extraordinary general meeting of shareholders on September 8, 2022, at MedinCell’s headquarters (3 rue des Frères Lumière, 34830 Jacou, France), which was chaired by Julie Alimi, Head of Legal of MedinCell. 
With a quorum of 60.34%, the shareholders have adopted all the resolutions proposed by the Management Board and, including, the approval of the annual and consolidated accounts for exercise ended March 31, 2022, the compensation policy applicable to the Chairman and members of the Management Board, the Chairman and the members of the Supervisory Board and the delegations granted to the Management Board in financial matters. As recommended by the Management Board, resolutions 31 and 32 were rejected.
The replay of the general meeting is available on: https://www.medincell.com/fr/investisseurs/#events_ 
Details on the vote results will be available soon on the company’s website: https://www.medincell.com/en/investors/#meeting_ 

Session en français

Rendez-vous le lundi 5 septembre à 18h30 (CEST) pour une vidéoconférence dédiée à la présentation des résolution de l'Assemblée Générale

English session

On Monday 5, September at 6.30 pm (CEST) participate in our videoconference dedicated to the presentation of the resolutions of the General meeting

Êtes-vous un actionnaire de MedinCell ? / Are you a MedinCell shareholder?
Vous êtes / You are :
This field is for validation purposes and should be left unchanged.

CONTACT

  • This field is for validation purposes and should be left unchanged.